US2022242921A1PendingUtilityA1
Novel peptide derived from pep27 peptide and uses thereof
Est. expiryFeb 1, 2041(~14.5 yrs left)· nominal 20-yr term from priority
A61Q 17/005A61K 8/64C12R 2001/46C07K 14/3156A23K 20/195A61K 38/00A61P 31/04A23L 33/18A01N 63/50A23K 20/147A61Q 19/00A23B 2/783Y02A50/30A23V 2002/00A61Q 19/10A61Q 19/007
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A peptide according to an embodiment of the present in which, in the amino acid sequence of SEQ ID NO: 1, (i) 2nd and 4th amino acids are each substituted with tryptophan (W); (ii) 2nd, 4th, 11st and 13rd amino acids are each substituted with tryptophan; and (iii) 2nd, 4th, 19th, 20th, 22nd, 23rd, 26th and 27th amino acids are each substituted with tryptophan. The peptide can be usefully applied as an active ingredient for antibiotics, cosmetic compositions, food additives, feed additives, biological pesticides and quasi-drugs.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A peptide in which, in the amino acid sequence of SEQ ID NO: 1,
(i) 2 nd and 4 th amino acids are each substituted with tryptophan (W); (ii) 2 nd , 4 th , 11 st and 13 rd amino acids are each substituted with tryptophan; or (iii) 2 nd , 4 th , 19 th , 20 th , 22 nd , 23 rd , 26 th and 27 th amino acids are each substituted with tryptophan.
2 . The peptide according to claim 1 , wherein the peptide consists of the amino acid sequence of SEQ ID NO: 2.
3 . The peptide according to claim 1 , wherein the peptide consists of the amino acid sequence of SEQ ID NO: 3.
4 . The peptide according to claim 1 , wherein the peptide consists of the amino acid sequence of SEQ ID NO: 4.
5 . An antimicrobial composition comprising the peptide according to claim 1 as an active ingredient.
6 . The antimicrobial composition according to claim 5 , wherein the antimicrobial composition is a pharmaceutical composition.
7 . The antimicrobial composition according to claim 5 , wherein the antimicrobial composition is any one selected from the group consisting of a cosmetic compositions, a food additive, a feed additive, a biological pesticide, an antiseptic composition and a quasi-drug compositions.
8 . A method of killing or reducing a growth of a microorganism comprising at least one selected from the group consisting of gram-positive bacteria, gram-negative bacteria and antibiotics-tolerant bacteria, the method comprising administering a composition comprising the peptide of claim 1 to a subject in need thereof.
9 . The method of claim 8 , wherein the microorganism comprises the gram-positive bacteria selected from the group consisting of Starphylococcus aureus, Bacillus subtilis, Listeria monocytogenes and a combination thereof.
10 . The method of claim 8 , wherein the microorganism comprises the gram-negative bacteria selected from the group consisting of Escherichia coli, Pseudomonas aeruginosa, Salmonella typhimurium and a combination thereof.
11 . The method of claim 8 , wherein the microorganism comprises the antibiotics-tolerant bacteria selected from the group consisting of Starphylococcus aureus ( S. aureus ), Escherichia coli ( E. coli ), Pseudomonas aeruginosa ( P. aeruginosa ), Salmonella typhimurium ( S. typhimurium ), and a combination thereof, which have antibiotic tolerance.
12 . The method of claim 8 , wherein the peptide consists of the amino acid sequence of SEQ ID NO: 2.
13 . The method of claim 8 , wherein the peptide consists of the amino acid sequence of SEQ ID NO: 3.
14 . The method of claim 8 , wherein the peptide consists of the amino acid sequence of SEQ ID NO: 4.Join the waitlist — get patent alerts
Track US2022242921A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.